https://www.biopharmadive.com/news/verdiva-obesity-biotech-startup-launch-sciwind-china/736880/
Verdiva starts up with $411M and a portfolio of obesity drugs from China | BioPharma Dive
The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind Biosciences, led by an oral therapy...
https://www.fiercebiotech.com/keyword/verdiva-bio
Verdiva Bio | Fierce Biotech
biofierce
https://verdivabio.com/
Verdiva Bio
Mar 16, 2026 - Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications...
bio